Live tape
Top 8, mentions 7d7,069GOOGL1,583 mentions▲ +0.03NKE1,463 mentions▲ +0.03META1,021 mentions▲ +0.05NVDA886 mentions▲ +0.09TSLA603 mentions▲ +0.05MSFT515 mentions▲ +0.04RBA500 mentions▲ +0.05AMZN498 mentions▲ +0.06

Equity · Healthcare

CDNA

NASDAQ

CareDx, Inc.

$65.01 +1.58% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 30, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$80 $20 6 Jul 30 Sep

The line runs $29.08 on 6 July through $65.01 on 30 September, on a scale from $20 to $80. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of CDNA over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $29.08 on 6 July 2026 through $65.01 on 30 September 2026.

Market cap $3.4B
P/E (TTM) 31.4
52-week range $14 – $65.01
Avg volume 73.4K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 30, 2026

CDNA insider trades

SEC Form 4 · last 90 days · newest reported trade 5 Aug 2026
Open-market buys 0
Open-market sells 6
Net sold $9.40M
Non-trade filings 5
Date Insider Type Shares Value
05 Aug 2026 Bickerstaff George Director Sell 20,000 $926K
05 Aug 2026 Novack Jeffrey Adam Secretary and General Counsel Sell 2,688 $124K
04 Aug 2026 COURNOYER CHRISTINE Director Sell 16,000 $751K
04 Aug 2026 Goldberg Michael Director Sell 44,700 $2.10M
16 Jul 2026 Hanna John Walter JR President and CEO Sell 118,000 $4.46M
16 Jul 2026 Valantine Hannah Director Sell 28,779 $1.04M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
12 Sep 2026 Kennedy Keith CFO & COO Tax withheld 8,220 $430K
12 Sep 2026 Meng Jessica Chief Commercial Officer Tax withheld 6,688 $350K
01 Aug 2026 Novack Jeffrey Adam Secretary and General Counsel Tax withheld 2,872 $137K
16 Jul 2026 Hanna John Walter JR President and CEO Option exercise 118,000 $968K
16 Jul 2026 Valantine Hannah Director Option exercise 28,779 $425K

CDNA reported financials

SEC EDGAR XBRL

CDNA reported revenue of $379.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$21.4M.

Figure Reported Period
Revenue $379.8M 31 Dec 2025 fiscal year
Net income −$21.4M 31 Dec 2025 fiscal year
Diluted EPS −$0.40 31 Dec 2025 fiscal year
Total assets $533.0M 30 Jun 2026 at period end
Total equity $425.6M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CDNA earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $2.07 —
31 Mar 2026 Q1 2026 $0.05 —
31 Dec 2025 FY 2025 $-0.40 —
30 Sep 2025 Q3 2025 $0.03 —
30 Jun 2025 Q2 2025 $-0.16 —
31 Mar 2025 Q1 2025 $-0.19 —
31 Dec 2024 FY 2024 $0.93 —
30 Sep 2024 Q3 2024 $-0.20 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CDNA institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a CDNA position for the quarter ended 30 Jun 2026 — a combined $152.0M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
ARK Investment Management Held (±25%) −12.3% shares 1,953,531 $55.7M
Renaissance Technologies Held (±25%) +4.9% shares 1,242,959 $35.4M
D. E. Shaw & Co. Added +30.0% shares 1,137,660 $32.4M
Two Sigma Investments Added +73.6% shares 401,987 $11.5M
AQR Capital Management Trimmed −30.0% shares 244,375 $7.0M
Man Group Held (±25%) −23.7% shares 126,962 $3.6M
Citadel Advisors Added +27.1% shares 106,984 $3.0M
Millennium Management New position 73,809 $2.1M
Tudor Investment Corp New position 25,842 $736K
Marshall Wace New position 17,898 $510K

Source: SEC EDGAR 13F filings

CDNA fails-to-deliver

SEC CNS data

On 11 Sep 2026, 155 shares of CDNA failed to deliver (about $8K) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
11 Sep 2026 155 $8K <0.001%
10 Sep 2026 60 $3K <0.001%
09 Sep 2026 122 $6K <0.001%
26 Aug 2026 11,711 $595K 0.023%
24 Aug 2026 271 $13K 0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in CDNA

STOCK Act disclosures

The most recent congressional trade disclosed in CDNA is a sale by Daniel S. Goldman (house, NY), dated 06 Mar 2023.

Date Member Type Amount
06 Mar 2023 filed 17 Apr 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K

Source: U.S. House of Representatives financial disclosures